0001209191-21-051912.txt : 20210817 0001209191-21-051912.hdr.sgml : 20210817 20210817170106 ACCESSION NUMBER: 0001209191-21-051912 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210816 FILED AS OF DATE: 20210817 DATE AS OF CHANGE: 20210817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beeler Brian K CENTRAL INDEX KEY: 0001641580 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 211183560 MAIL ADDRESS: STREET 1: C/O HORIZON PHARMA PLC STREET 2: 520 LAKE COOK ROAD, SUITE 520 CITY: DEERFIELD STATE: IL ZIP: 60015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-16 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001641580 Beeler Brian K C/O HORIZON THERAPEUTICS PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 4 IRELAND 0 1 0 0 EVP, General Counsel Ordinary Shares 2021-08-16 4 M 0 65857 22.14 A 165816 D Ordinary Shares 2021-08-16 4 S 0 74898 106.00 D 90918 D Stock Option (Right to Buy) 22.14 2021-08-16 4 M 0 65857 0.00 D 2025-03-22 Ordinary Shares 65857 0 D The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.6312 to $106.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option is fully vested and exercisable. /s/ Miles W. McHugh, Attorney-in-Fact 2021-08-17